Showing results (1421-1430 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|December 30, 2020
Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision makingShuxian Chen, Jennifer Graff, Sophia Yun, et al.Journal of Managed Care & Specialty Pharmacy|December 30, 2020
Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort studyChanadda Chinthammit, David R Axon, Lea Mollon, et al.Journal of Managed Care & Specialty Pharmacy|December 28, 2019
AMCP Partnership Forum: Principles for Sound Pharmacy and Therapeutics (P&T) Committee Practices: What's Next?Journal of Managed Care & Specialty Pharmacy|December 28, 2019
Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical ContractsJoseph T Kannarkat, Chester B Good, Erin Kelly, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid ProgramShellie L Keast, Bethany Holderread, Terry Cothran, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty PopulationDominic Paolella, Elizabeth Cherry, Jacob A Jolly, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Physician Perceptions of Step Therapy Prescribing RequirementsMichael A Fischer, Aaron S Kesselheim, Zhigang Lu, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Two-Way Clinical Messaging in a CML Specialty Pharmacy Service ModelChristine Sawicki, Kayla E Friend, Ruchik Patel, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor InhibitorsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer PerspectiveDaniel Stellato, Margaret E Gerbasi, Briana Ndife, et al.Pageof 185